AlphaFold predicted structure
SLC35A3 · Q9Y2D2

Mean pLDDT
89.3/ 100
Confident
325 residues
Confidence breakdown
- Very high(≥ 90)72%
- Confident(70–90)19%
- Low(50–70)7%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 35 member A3
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Arthrogryposis
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalCongenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalautism spectrum disorder - epilepsy - arthrogryposis syndrome
Autism spectrum disorder-epilepsy-arthrogryposis syndrome
developmental disorder of mental health
epilepsy syndrome
distal arthrogryposis
hereditary disease
neurodegenerative disease
seasonal allergic rhinitis
arthrogryposis multiplex congenita
colorectal carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
UDP-N-acetylglucosamine transporter
Transports diphosphate-N-acetylglucosamine (UDP-GlcNAc) from the cytosol into the lumen of the Golgi apparatus, functioning as an antiporter that exchanges UDP-N-acetyl-alpha-D-glucosamine for UMP (PubMed:10393322). May supply UDP-GlcNAc as substrate for Golgi-resident glycosyltransferases that generate highly branched, multiantennary complex N-glycans and keratan sulfate (PubMed:23766508, PubMed:34981577). However, the exact role of SLC35A3 still needs to be elucidated, it could be a member of a catalytically more efficient multiprotein complex rather than function independently as a single transporter (PubMed:32938718)
SLC35A3 · Q9Y2D2

Mean pLDDT
89.3/ 100
Confident
325 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0